Unlock stock picks and a broker-level newsfeed that powers Wall Street.
Taipei Exchange - Delayed Quote TWD

ShareHope Medicine Co., Ltd. (8403.TWO)

Compare
25.75
-2.85
(-9.97%)
At close: 1:24:18 PM GMT+8
Loading Chart for 8403.TWO
  • Previous Close 28.60
  • Open 25.75
  • Bid --
  • Ask --
  • Day's Range 25.75 - 25.75
  • 52 Week Range 25.75 - 32.88
  • Volume 292,868
  • Avg. Volume 78,835
  • Market Cap (intraday) 3.375B
  • Beta (5Y Monthly) 0.58
  • PE Ratio (TTM) 16.94
  • EPS (TTM) 1.52
  • Earnings Date --
  • Forward Dividend & Yield 0.40 (1.37%)
  • Ex-Dividend Date Aug 27, 2024
  • 1y Target Est --

ShareHope Medicine Co., Ltd. provides integrated medical services in Taiwan. It engages in the health management and operation activities; human resource dispatch of professional medical staff; provision of medical, pharmaceutical, and health devices, as well as long-distance health care services; and rental of medical devices. ShareHope Medicine Co., Ltd. was founded in 2003 and is based in Taoyuan City, Taiwan.

www.share-hope.com

--

Full Time Employees

December 31

Fiscal Year Ends

Recent News: 8403.TWO

View More

Performance Overview: 8403.TWO

Trailing total returns as of 4/7/2025, which may include dividends or other distributions. Benchmark is TSEC CAPITALIZATION WEIGHTED ST (^TWII) .

YTD Return

8403.TWO
11.05%
TSEC CAPITALIZATION WEIGHTED ST (^TWII)
16.51%

1-Year Return

8403.TWO
13.60%
TSEC CAPITALIZATION WEIGHTED ST (^TWII)
5.43%

3-Year Return

8403.TWO
10.24%
TSEC CAPITALIZATION WEIGHTED ST (^TWII)
11.96%

5-Year Return

8403.TWO
10.60%
TSEC CAPITALIZATION WEIGHTED ST (^TWII)
92.39%

Compare To: 8403.TWO

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: 8403.TWO

View More

Valuation Measures

Annual
As of 4/2/2025
  • Market Cap

    3.75B

  • Enterprise Value

    4.26B

  • Trailing P/E

    18.82

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    0.87

  • Price/Book (mrq)

    1.05

  • Enterprise Value/Revenue

    0.99

  • Enterprise Value/EBITDA

    7.90

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    3.67%

  • Return on Assets (ttm)

    0.99%

  • Return on Equity (ttm)

    2.45%

  • Revenue (ttm)

    4.28B

  • Net Income Avi to Common (ttm)

    157.13M

  • Diluted EPS (ttm)

    1.52

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    1.44B

  • Total Debt/Equity (mrq)

    50.32%

  • Levered Free Cash Flow (ttm)

    104.88M

Research Analysis: 8403.TWO

View More

Company Insights: 8403.TWO

Research Reports: 8403.TWO

View More

People Also Watch